mci 154 has been researched along with olprinone in 1 studies
| Studies (mci 154) | Trials (mci 154) | Recent Studies (post-2010) (mci 154) | Studies (olprinone) | Trials (olprinone) | Recent Studies (post-2010) (olprinone) |
|---|---|---|---|---|---|
| 65 | 1 | 0 | 157 | 25 | 43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamaguchi, K; Yamakawa, H; Yokoyama, M | 1 |
1 other study(ies) available for mci 154 and olprinone
| Article | Year |
|---|---|
Beneficial effects of a Ca2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor.
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Humans; Imidazoles; Myocardial Infarction; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Ventricular Dysfunction, Left | 1997 |